What is Equilibria?
Equilibria distinguishes itself in the competitive CBD landscape by offering premium, farm-fresh, full-spectrum CBD products tailored for women. The brand emphasizes personalized dosage support, guided by experienced cannabis educators, and ensures unparalleled quality through its exclusive bioscience partner. Their product line includes daily essentials like softgels and drops, alongside relief-focused items, available through a la carte purchases or subscription boxes. Equilibria's mission is to advance balance and well-being for women globally.
How much funding has Equilibria raised?
Equilibria has raised a total of $2.1M across 2 funding rounds:
Debt
$150K
Angel/Seed
$2M
Debt (2020): $150K with participation from PPP
Angel/Seed (2020): $2M led by Hyde Park Angels and Salveo Capital
Key Investors in Equilibria
Hyde Park Angels
Hyde Park Angels is a venture capital group founded in 2007 and based in Chicago, IL, which focuses on angel investments.
Salveo Capital
Salveo Capital is focused on funding the future of the legal cannabis industry by applying institutional quality discipline to company vetting, investment structures, and portfolio management. The company aims to empower entrepreneurs by partnering with driven individuals and providing support beyond just capital.
What's next for Equilibria?
The substantial enterprise-level funding indicates Equilibria is poised for significant scaling and market expansion. This capital injection will likely fuel further product development, enhance marketing initiatives to reach a broader audience, and potentially strengthen its supply chain and distribution networks. The company's focus on a specific demographic (women) and its commitment to quality and personalized support position it for sustained growth in the evolving wellness and cannabis industries.
See full Equilibria company page
